Polyunsaturated Fatty Acids and Atherosclerosis: Insights from Pre‐Clinical Studies

Published on Jan 1, 2019in European Journal of Lipid Science and Technology1.852
· DOI :10.1002/ejlt.201800029
Dipak Purshottam Ramji30
Estimated H-index: 30
(Cardiff University)
Atherosclerosis and its complications are responsible for more global deaths than any other disease. Atherosclerosis is a chronic inflammatory disease of medium and large arteries that can cause clinical complications such as myocardial infarction and cerebrovascular accidents. Current therapies against atherosclerosis mainly target the dyslipidemia associated with the disease and are associated with considerable residual risk for cardiovascular disease together with various side effects. In addition, the outcomes of clinical trials on many pharmaceutical agents against promising therapeutic targets have been disappointing. This has resulted in considerable recent interest on nutraceuticals in the prevention of atherosclerosis and as add‐on with current pharmaceutical therapies. However, nutraceutical research has considerably lagged those on pharmaceuticals on two key aspects, large clinical trials and mechanistic insights. The latter forms the focus of this review in relation to the potential beneficial actions of polyunsaturated fatty acids as identified from pre‐clinical studies.
Figures & Tables
  • References (76)
  • Citations (2)
📖 Papers frequently viewed together
26 Citations
7 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Joe W. E. Moss (Cardiff University)H-Index: 7
#2Jessica O. Williams (Cardiff University)H-Index: 3
Last. Dipak Purshottam Ramji (Cardiff University)H-Index: 30
view all 3 authors...
Atherosclerosis, a chronic inflammatory disorder of medium and large arteries and an underlying cause of cardiovascular disease (CVD), is responsible for a third of all global deaths. Current treatments for CVD, such as optimized statin therapy, are associated with considerable residual risk and several side effects in some patients. The outcome of research on the identification of alternative pharmaceutical agents for the treatment of CVD has been relatively disappointing with many promising le...
15 CitationsSource
#1Emelia J. BenjaminH-Index: 154
#2Salim S. ViraniH-Index: 37
Last. Paul MuntnerH-Index: 92
view all 51 authors...
Each chapter listed in the Table of Contents (see next page) is a hyperlink to that chapter. The reader clicks the chapter name to access that chapter. Each chapter listed here is a hyperlink. Click on the chapter name to be taken to that chapter. Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together in a single document the most up-to-date statistics r...
1,241 CitationsSource
#1Francesco SofiH-Index: 35
#2Monica DinuH-Index: 8
Last. Alessandro CasiniH-Index: 44
view all 10 authors...
Background:Only a few randomized dietary intervention studies that investigated the effects of lacto-ovo vegetarian diet (Vd) in clinically healthy omnivorous subjects are available. Methods:We ran...
12 CitationsSource
#1Theingi Aung (Medical Research Council)H-Index: 6
#2Jim Halsey (Medical Research Council)H-Index: 10
Last. Robert Clarke (Medical Research Council)H-Index: 135
view all 16 authors...
Importance Current guidelines advocate the use of marine-derived omega-3 fatty acids supplements for the prevention of coronary heart disease and major vascular events in people with prior coronary heart disease, but large trials of omega-3 fatty acids have produced conflicting results. Objective To conduct a meta-analysis of all large trials assessing the associations of omega-3 fatty acid supplements with the risk of fatal and nonfatal coronary heart disease and major vascular events in the fu...
146 CitationsSource
#1Tetsu Watanabe (YU: Yamagata University)H-Index: 21
#2Kaoru Ando (YU: Yamagata University)H-Index: 3
view all 18 authors...
Abstract Background There is a residual risk of coronary heart disease (CHD) despite intensive statin therapy for secondary prevention. The aim of this study was to investigate whether coronary plaque regression and stabilization are reinforced by the addition of eicosapentaenoic acid (EPA) to high-dose pitavastatin (PTV). Methods We enrolled 193 CHD patients who underwent percutaneous coronary intervention (PCI) in six hospitals. Patients were randomly allocated to the PTV group (PTV 4 mg/day, ...
19 CitationsSource
#1Esther Tortosa-Caparrós (University of Murcia)H-Index: 1
#2Diana Navas-Carrillo (University of Murcia)H-Index: 5
Last. Esteban Orenes-Piñero (University of Murcia)H-Index: 12
view all 4 authors...
ABSTRACTA lipid excess produces a systemic inflammation process due to tumor necrosis factor-α, interleukin-6 and C-reactive protein synthesis. Simultaneously, this fat excess promotes the appearance of insulin resistance. All this contributes to the development of atherosclerosis and increases the risk of cardiovascular diseases (CVDs). On the other hand, polyunsaturated fatty acids (PUFAs), especially eicosapentaenoic acid and docosahexaenoic acid (omega 3), and arachidonic acid (omega 6) have...
37 CitationsSource
#1Andrew P. Sage (University of Cambridge)H-Index: 18
#2Ziad Mallat (University of Cambridge)H-Index: 73
A.S. and Z.M. are supported by grants from the British Heart Foundation. Z.M. is also supported by FP7 VIA project and by Institut National de la Sante et de la Recherche Medicale (INSERM).
10 CitationsSource
#1Ira Tabas (CUMC: Columbia University Medical Center)H-Index: 9
#2Aron H. Lichtman (Brigham and Women's Hospital)H-Index: 85
Atherosclerosis is an arterial disease process characterized by the focal subendothelial accumulation of apolipoprotein-B-containing lipoproteins, immune and vascular wall cells, and extracellular matrix. The lipoproteins acquire features of damage-associated molecular patterns and trigger first an innate immune response, dominated by monocyte-macrophages, and then an adaptive immune response. These inflammatory responses often become chronic and non-resolving and can lead to arterial damage and...
95 CitationsSource
BackgroundExperimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. MethodsWe conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The ...
1,434 CitationsSource
#1Kevin C. MakiH-Index: 46
Last. Peter P. Toth (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 37
view all 4 authors...
Background Randomized controlled trials (RCTs) assessing use of long-chain omega-3 polyunsaturated fatty acids (LC-OM3), primarily eicosapentaenoic acid, and/or docosahexaenoic acid have shown mixed results. Objective The objectives of the study were to update and further explore the available RCT data regarding LC-OM3 supplementation and risk for cardiac death and to propose testable hypotheses for the mixed results obtained in RCTs regarding supplemental LC-OM3 use and cardiac risk. Methods A ...
30 CitationsSource
Cited By2
: The production of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) concentrate from cobia liver oil by acetone fractionation of fatty acid salts was investigated in this study. A three-level-three-factor Box-Behnken design was used to evaluate the effects of reaction time, amount of NaOH added, and acetone ratio on the responses (DHA and EPA content and recovery). The results showed that the amount of NaOH added was the most important factor in the process. The DHA content showed an ...
#1Ronan LordanH-Index: 7
#1Ronan Lordan (UPenn: University of Pennsylvania)
Last. Ioannis ZabetakisH-Index: 24
view all 4 authors...
Since the discovery that Greenlandic Innuits had a lower risk of developing cardiovascular diseases (CVD) due to their diet of fish and as a consequence high polyunsaturated fatty acids (PUFA) intake, scientific interest of the therapeutic value of n-3 PUFA such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) has grown. It is well-accepted that fish consumption is associated with the prevention of inflammation and CVD. As a result fish oil supplements and nutraceuticals are widely ...
2 CitationsSource
#1Ronan Lordan (UL: University of Limerick)H-Index: 7
#2Alexandros Tsoupras (UL: University of Limerick)H-Index: 5
Last. Ioannis Zabetakis (UL: University of Limerick)H-Index: 24
view all 3 authors...
Abstract Platelets are central to inflammation-related manifestations of cardiovascular diseases (CVD) such as atherosclerosis. Platelet-activating factor (PAF), thrombin, thromboxane A2 (TxA2), and adenosine diphosphate (ADP) are some of the key agonists of platelet activation that are at the intersection between a plethora of inflammatory pathways that modulate pro-inflammatory and coagulation processes. The aim of this article is to review the role of platelets and the relationship between th...
2 CitationsSource
#1Victoria O'Morain (Cardiff University)H-Index: 1
#2Dipak Purshottam Ramji (Cardiff University)H-Index: 30
Atherosclerosis, the underlying cause of cardiovascular diseases such as myocardial infarction, cerebrovascular accident and peripheral vascular disease, is the leading cause of global mortality. Current therapies against atherosclerosis, which mostly target the dyslipidemia associated with the disease, have considerable residual risk for cardiovascular disease together with various side effects. In addition, the outcomes from clinical trials on many promising pharmaceutical agents against ather...
#1Hayley Gallagher (Cardiff University)H-Index: 3
#2Jessica O. Williams (Cardiff University)H-Index: 3
Last. Dipak Purshottam Ramji (Cardiff University)H-Index: 30
view all 13 authors...
Abstract Atherosclerosis and its complications are responsible for one in three global deaths. Nutraceuticals show promise in the prevention and treatment of atherosclerosis but require an indepth understanding of the mechanisms underlying their actions. A previous study showed that the omega-6 fatty acid, dihomo-γ-linolenic acid (DGLA), attenuated atherosclerosis in the apolipoprotein E deficient mouse model system. However, the mechanisms underlying such protective effects of DGLA are poorly u...
2 CitationsSource
#1Amit Kugler (BGU: Ben-Gurion University of the Negev)H-Index: 1
#2Boris Zorin (BGU: Ben-Gurion University of the Negev)H-Index: 3
Last. Inna Khozin-Goldberg (BGU: Ben-Gurion University of the Negev)H-Index: 31
view all 12 authors...
: Lobosphaera incisa is a green microalga that accumulates high levels of the valuable omega-6 long-chain polyunsaturated fatty acids (LC-PUFA) arachidonic acid (ARA, 20:4n-6) in triacylglycerols (TAG) under nitrogen (N) starvation. LC-PUFA accumulation is a rare trait in photosynthetic microalgae with insufficiently understood physiological significance. In this study, RNAi was attempted, for the first time in L. incisa, to produce knockdown lines for the Δ5 desaturase gene. Two lines, termed m...
1 CitationsSource